112 related articles for article (PubMed ID: 11332280)
1. Modest increases in the titers of helper virus-free herpes simplex virus 1 (HSV-1) vectors by packaging in a cell line with inducible expression of HSV-1 VP16 or by treatment with N,N'-hexamethylene-bis-acetamide.
Sun M; Lee J; Yu L; Geller AI
Acta Virol; 2000 Dec; 44(6):365-9. PubMed ID: 11332280
[TBL] [Abstract][Full Text] [Related]
2. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.
Saeki Y; Fraefel C; Ichikawa T; Breakefield XO; Chiocca EA
Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922
[TBL] [Abstract][Full Text] [Related]
3. Optimal purification method for Herpes-based viral vectors that confers minimal cytotoxicity for systemic route of vector administration.
Sia KC; Wang GY; Ho IA; Khor HY; Miao L; Hui KM; Lam PY
J Virol Methods; 2007 Feb; 139(2):166-74. PubMed ID: 17074404
[TBL] [Abstract][Full Text] [Related]
4. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.
Grant KG; Krisky DM; Ataai MM; Glorioso JC
Biotechnol Bioeng; 2009 Mar; 102(4):1087-97. PubMed ID: 18828174
[TBL] [Abstract][Full Text] [Related]
5. Helper virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's disease and other neurological disorders.
Geller AI; Yu L; Wang Y; Fraefel C
Exp Neurol; 1997 Mar; 144(1):98-102. PubMed ID: 9126158
[TBL] [Abstract][Full Text] [Related]
6. Long-term persistence of defective HSV-1 vectors in the rat brain is demonstrated by reactivation of vector gene expression.
Starr PA; Lim F; Grant FD; Trask L; Lang P; Yu L; Geller AI
Gene Ther; 1996 Jul; 3(7):615-23. PubMed ID: 8818649
[TBL] [Abstract][Full Text] [Related]
7. Cytodifferentiating agents affect the replication of herpes simplex virus type 1 in the absence of functional VP16.
Preston CM; McFarlane M
Virology; 1998 Sep; 249(2):418-26. PubMed ID: 9791032
[TBL] [Abstract][Full Text] [Related]
8. Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titers.
Bowers WJ; Howard DF; Brooks AI; Halterman MW; Federoff HJ
Gene Ther; 2001 Jan; 8(2):111-20. PubMed ID: 11313780
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a novel foreign gene delivery system combining an HSV amplicon with an attenuated replication-competent virus, HSV-1 HF10.
Zhang L; Daikoku T; Ohtake K; Ohtsuka J; Nawa A; Kudoh A; Iwahori S; Isomura H; Nishiyama Y; Tsurumi T
J Virol Methods; 2006 Nov; 137(2):177-83. PubMed ID: 16854473
[TBL] [Abstract][Full Text] [Related]
10. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.
Lilley CE; Groutsi F; Han Z; Palmer JA; Anderson PN; Latchman DS; Coffin RS
J Virol; 2001 May; 75(9):4343-56. PubMed ID: 11287583
[TBL] [Abstract][Full Text] [Related]
11. Improved titers for helper virus-free herpes simplex virus type 1 plasmid vectors by optimization of the packaging protocol and addition of noninfectious herpes simplex virus-related particles (previral DNA replication enveloped particles) to the packaging procedure.
Sun M; Zhang GR; Yang T; Yu L; Geller AI
Hum Gene Ther; 1999 Aug; 10(12):2005-11. PubMed ID: 10466634
[TBL] [Abstract][Full Text] [Related]
12. Hexamethylene bisacetamide leads to reduced helper virus-free HSV-1 amplicon expression titers via suppression of ICP0.
Burris CA; de Silva S; Narrow WC; Casey AE; Lotta LT; Federoff HJ; Bowers WJ
J Gene Med; 2008 Feb; 10(2):152-64. PubMed ID: 18058952
[TBL] [Abstract][Full Text] [Related]
13. Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors.
Sena-Esteves M; Hampl JA; Camp SM; Breakefield XO
J Gene Med; 2002; 4(3):229-39. PubMed ID: 12112640
[TBL] [Abstract][Full Text] [Related]
14. A novel approach for herpes simplex virus type 1 amplicon vector production, using the Cre-loxP recombination system to remove helper virus.
Logvinoff C; Epstein AL
Hum Gene Ther; 2001 Jan; 12(2):161-7. PubMed ID: 11177553
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a potent refractory state and persistence of herpes simplex virus 1 in cell culture.
Barreca C; O'Hare P
J Virol; 2006 Sep; 80(18):9171-80. PubMed ID: 16940528
[TBL] [Abstract][Full Text] [Related]
16. A modular set of helper-dependent herpes simplex virus expression vectors.
Strathdee CA; McLeod MR
Mol Ther; 2000 May; 1(5 Pt 1):479-85. PubMed ID: 10933969
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemia.
Zibert A; Thomassen A; Müller L; Nguyen L; Glouchkova L; Fraefel C; Roskrow M; Meisel R; Dilloo D
Gene Ther; 2005 Dec; 12(23):1707-17. PubMed ID: 16034459
[TBL] [Abstract][Full Text] [Related]
18. Highly efficient regulation of gene expression by tetracycline in a replication-defective herpes simplex viral vector.
Yao F; Theopold C; Hoeller D; Bleiziffer O; Lu Z
Mol Ther; 2006 Jun; 13(6):1133-41. PubMed ID: 16574491
[TBL] [Abstract][Full Text] [Related]
19. Identification of a replication-defective herpes simplex virus for recombinant adeno-associated virus type 2 (rAAV2) particle assembly using stable producer cell lines.
Toublanc E; Benraiss A; Bonnin D; Blouin V; Brument N; Cartier N; Epstein AL; Moullier P; Salvetti A
J Gene Med; 2004 May; 6(5):555-64. PubMed ID: 15133766
[TBL] [Abstract][Full Text] [Related]
20. Enhanced long-term expression from helper virus-free HSV-1 vectors packaged in the presence of deletions in genes that modulate the function of VP16, U L 46 and U L 47.
Liu M; Tang J; Wang X; Yang T; Geller AI
J Neurosci Methods; 2005 Jun; 145(1-2):1-9. PubMed ID: 15922021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
